Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
Neptune Wellness Solutions has entered into an equity partnership with a media company to drive the visibility of its hemp-derived CBD products in the US market.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
FDA is continuing to crack down on the legality of CBD when a case comes across its desk, despite a call for an official enforcement discretion policy.
The United Natural Products Alliance has signed a Memorandum of Understanding (MOU) with the University of Arkansas for Medical Sciences, allowing industry stakeholders access to the medical school’s analytical, technical and policy expertise.
With barely two weeks left before the industry makes it annual pilgrimage to Las Vegas for SupplySide West, we look ahead to the events educational workshop program.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
The US House of Representatives is expected to vote today on a bill that would clear the way for full banking services for companies dealing in hemp/CBD products.
NSF International has unveiled a new certification program for the hemp industry, which the organization says will help address the ongoing quality questions in this sector.
With 332% growth year-on-year and $52 million in sales, cannabidiol (CBD) has taken the top spot as the best-selling herbal supplement in the natural channel, according to the 2018 HerbalGram Herb Market Report by the American Botanical Council.
Senate Majority Leader Mitch McConnell has introduced language into a congressional spending report that would require the FDA to issue formal enforcement discretion on the sale of hemp-derived CBD products within 120 days, clearing a path for the lawful...
Hemp/CBD player Aurora Cannabis announced a huge gain in sales in a fiscal year that saw the company sign a ‘research partnership’ with the UFC, a combat sports league.
Colorado-based Geocann has launched two CBG (cannabigerol) formulations, optimizing absorption and bioavailability by utilizing the VESIsorb drug delivery system.
Medical Marijuana Inc, despite its name one of the early players in the hemp/CBD supplement field, has announced sales increases topping 30% and a move to develop products based on additional cannabinoids.
The high variability of hemp plants now being grown in North America means claims of standardization should be take with a grain of salt, a botanical expert says.
Interest in CBD is “off the charts,” but those mulling the regulatory path forward for the hottest functional ingredient of the moment might be well advised to consider how other cannabinoids will fit into the regulatory framework going forward, says...
In a development reflective of the rapidly developing hemp and cannabis markets, research firm BDS Analytics has announced $7 million in new financing.
Colorado Gov. Jared Polis said the state intends to maintain its lead in the hemp industry by putting the full weight of state government behind its farmers and extractors. The state has taken a lead in shipping hemp plants and seeds to some Latin American...
FDA needs to act quickly on CBD regulations before a rapidly developing patchwork quilt of new rules promulgated in lower jurisdictions unduly complicates the situation.
The rollout of New Age Beverages’ CBD-infused beverages has been delayed owing to the regulatory uncertainty over CBD, which makes navigating the territory “as murky as the Strait of Hormuz,” CEO Brent Willis told analysts yesterday.
A key element of the CBD debate will be determining best practices of when and how to measure the THC content of products, said an expert with long experience in the botanicals field.
LifeScienceRisk (LSR) has launched a new cannabis program for the booming category, with coverage for all stages of the chain, from growers and processors right through to retail stores.
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
In an editorial published yesterday former FDA Commissioner Scott Gottlieb said the agency needs to act quickly on CBD, but must not compromise on its mission of safety in doing so.
The authors of a guest editorial published by the American Botanical Council have proposed a regulatory structure for cannabis products that relies on federal support and coordination for state initiatives.
Europe’s cannabidiol food and supplements market was on display at a recent CBD expo in Berlin, with CBD supplement and cosmetic manufacturers reporting impressive margins in a controversial category defined by booming sales and baffling regulations.
FDA said today it will have an update on a new regulatory structure for CBD by early fall. The announcement came via a press release on another warning issued to a CBD marketer making illegal disease claims.
The Council for Responsible Nutrition believes FDA has ample authority to regulate CBD in an expeditious manner, according to comments the trade organization filed on the federal docket this week.
Energy drink for e-sports, prebiotic powder by an iconic coffee company, and an entirely new brand specializing in performance gummies, here’s a quick round-up of recent product launches:
Hemp product manufacturer Haleigh’s Hope says it is raising a quality flag in the hemp/CBD category by getting a GMP certification on its production facility from a third party verifier.
The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
An interim final rule on CBD is a viable way for FDA to break the logjam on this increasingly popular ingredient, according to the head of one industry trade organization.
French natural products specialist Robertet is bringing its supply chain experience to a joint venture on broad spectrum hemp extracts focused on the US market, the company announced recently.
The American Herbal Products Association is planning a hemp/CBD event in August in Colorado for dietary supplement companies interested in the ingredient.
Relevium Technologies, a Canadian development stage company focusing on online sales of dietary supplements and personal care products, is moving to acquire LifeLine Pharma, a Colombian cannabis company.
Australia's first trial to test the effects of CBD (cannabidiol) oil on individuals suffering from post-traumatic stress disorder (PTSD) will feature Bod Australia's proprietary CBD oil, MediCabilis.
Colorado has convened a commission to formulate an agricultural plan for the cultivation of industrial hemp in the state. A longtime supplement and natural foods industry consultant is among the participants.
Oregon Sen. Ron Wyden has put further pressure on FDA with a letter requesting a formal announcement of enforcement discretion on the CBD question while a more permanent regulatory solution is hashed out.
An amendment advocated by the Natural Products Association that would earmark funds for CBD regulation was including in the final version of the 2019 appropriations bill passed by the US House of Representatives.
Supplementation with a hemp-derived, CBD-rich extract for six weeks led to significant improvements in sleep and reductions in appetite, according to results of a randomized clinical trial in healthy adults.
Natural products online marketplace Thrive Market has temporarily halted sales of hemp-derived CBD products after its merchant processor demanded it cease selling them amid uncertainty over their legal status, but says it is in conversations with a new...
